Sesquiterpenoids and plasmin-inhibitory flavonoids from Blumea balsamifera

Journal of Natural Products

Volumn 68, Issue 3, 2005, Pages 447-449

  Osaki, Naoto ^a   Koyano, Takashi ^b   Kowithayakorn, Thaworn ^c   Hayashi, Masahiko ^d   Komiyama, Kanki ^d   Ishibashi, Masami ^a  

^a CHIBA UNIVERSITY   (Japan)

^b Temko Corporation   (Japan)

^c KHON KAEN UNIVERSITY   (Thailand)

^d KITASATO INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLUMEA BALSAMIFERA EXTRACT; ESTER DERIVATIVE; HERBACEOUS AGENT; PLANT EXTRACT; PLASMIN; PLASMIN INHIBITOR; SESQUITERPENOID; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; FLAVONOID; SESQUITERPENE;

ARTICLE; BLUMEA BALSAMIFERA; CANCER CELL CULTURE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL ASSAY; CYTOPATHOGENIC EFFECT; DRUG CYTOTOXICITY; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; IC 50; INFRARED SPECTROSCOPY; LEUKEMIA CELL LINE; MASS SPECTROMETRY; MEDICINAL PLANT; NONHUMAN; PLANT LEAF; PROTEIN DETERMINATION; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ANALYSIS; ASTERACEAE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; ISOLATION AND PURIFICATION; NUCLEAR MAGNETIC RESONANCE; THAILAND;

ASTERACEAE; BLUMEA BALSAMIFERA;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ASTERACEAE; DRUG SCREENING ASSAYS, ANTITUMOR; FLAVONOIDS; HUMANS; INHIBITORY CONCENTRATION 50; JURKAT CELLS; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PLANTS, MEDICINAL; PLASMIN; SESQUITERPENES; THAILAND;

EID: 17444369383     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np049622e     Document Type: Article

References (17)

1. (a) Toume, K.; Takahashi, M.; Koyano, T.; Kowithayakorn, T.; Yamaguchi, K.; Hayashi, M.; Komiyama, K.; Ishibashi, M. Tetrahedron 2004, 60, 10817-10824.
2. (b) Ohtsuki, T.; Koyano, T.; Kowithayakorn, T.; Sakai, S.; Kawahara, N.; Goda, Y.; Yamaguchi, N.; Ishibashi, M. Bioorg. Med. Chem. 2004, 12, 3841-3845.
3. (c) Ohtsuki, T.; Koyano, T.; Kowithayakorn, T.; Yamaguchi, N.; Ishibashi, M. Planta Med., 2004, 70, 1170-1173.
4. (d) Kawamoto, S.; Koyano, T.; Kowithayakorn, T.; Fujimoto, H.; Okuyama, E.; Hayashi, M.; Komiyama, K.; Ishibashi, M. Chem. Pharm. Bull. 2003, 51, 737-739.
5. Fujimoto, Y.; Soemartono, A.; Sumatra, M. Phytochemistry 1988, 27, 1109-1111.
6. Barua, N. C.; Sharma, R. P. Phytochemistry 1992, 31, 4040.
7. (a) Islam, Md. T.; Tahara, S. Phytochemistry 2000, 54, 901-907.
8. (b) Vasconcelos, J. M. J.; Silva, A. M. S.; Cavaleiro, J. A. S. Phytochemistry 1998, 49, 1421-1424.
9. (c) Urbatsch, L. E.; Mabry, T. J.; Miyakado, M.; Ohno, N.; Yoshioka, H. Phytochemistry 1976, 15, 440-441.
10. (d) Crins, W. J.; Bohm, B. A. Phytochemistry 1988, 27, 2647-2649.
11. (e) Rodriguez, E.; Carman, N. J.; Velde, G. V.; Mcreynolds, J. H.; Mabry, T. J. Phytochemistry 1972, 11, 3509-3514.
12. Marco, J. A.; Sanz-Cervera, J. F.; Yuste, A. Phytochemistry 1997, 45, 563-570.
13. Turner, C. J.; Tempesta, M. S.; Taylor, R. B.; Zagorski, M. G.; Termini, J. S.; Schroeder, D. R.; Nakanishi, K. Tetrahedron 1987, 43, 2789-2803.
14. 3-14/C-10.
15. 3-14/C-1.
16. 3-14. It may be biogenetically conceivable that an aldol-type C-C bond formation between C-1 and C-5 of compound 2 affords the same carbon skeleton of compound 1. This consideration may suggest that the C-7, C-9, and C-10 configurations of compound 2 are likely to be the same as that of 1.
17. Connolly, J. D.; Fakunle, C. O.; Rycroft, D. S. Tetrahedron Lett. 1984, 25, 3773-3776.